Can diabetes and obesity drugs also help the skin? The potential of GLP-1 agonists in dermatology
GLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity for their effectiveness in treating type 2 diabetes and obesity, but increasing evidence suggests their effects may be much broader. Recent studies indicate that they may also influence inflammatory processes responsible for the development of many skin […]